We assessed long-term functional outcomes after prophylactic total gastrectomy for CDH-1 mutations in otherwise asymptomatic, imaging-negative and endoscopic-biopsy-negative HDGC patients and compared them to symptomatic patients with HDGC. The gene discussed is CDH1; the disease is Familial gastric cancer.